<DOC>
	<DOCNO>NCT01213745</DOCNO>
	<brief_summary>This study investigate effectiveness use European Organisation Research Treatment cancer Core Quality Life Questionnaire ( EORTC QLQ-C30 + LC 13 ) identify target therapy patient lung cancer . The study ass whether use questionnaire result improvement QoL .</brief_summary>
	<brief_title>The Use Quality Life Questionnaire Patients With Lung Cancer</brief_title>
	<detailed_description>Patients lung cancer complete course treatment ( in-between treatment ) Royal Marsden Hospital would eligible inclusion study . Participants randomise 3 group . Group 1 - group complete QoL questionnaire receive target therapy doctor ( member oncology team ) clinic consultation . Group 2 - complete QoL questionnaire however questionnaire see doctor clinic consultation . Group 3 - control group complete QoL questionnaire clinic consultation . All patient complete diary contact health care professional study . The study last 6 week end study patient complete QoL questionnaire .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>male female age &gt; 18 year patient able adequately understand write spoken english diagnosis lung cancer ( non small cell , small cell , mesothelioma ) plan commence treatment ( chemotheraphy , targeted therapy , radioterhapy , surgery ) 6 week radically palliatively treated patient remain eligible patient whose toxicity primary treatment resolve stabilised period 7 day patient take part QoL study take part study require QoL questionnaire , extra visit investigation currently treatment ( chemotherapy , radiotherapy , surgery target therapy ) go toxicity treatment stablised ( require intervention within last 7 day )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>lung</keyword>
	<keyword>cancer</keyword>
	<keyword>quality life</keyword>
</DOC>